What are the diagnostic workup and treatment options for a patient presenting with sudden weakness of the lower extremities?

Sudden Weakness of Lower Extremities: Diagnostics and Treatment

For a patient presenting with sudden bilateral lower extremity weakness, immediately assess for Guillain-Barré syndrome (GBS) as the primary diagnosis and initiate treatment with intravenous immunoglobulin (0.4 g/kg daily for 5 days) or plasma exchange (200-250 ml/kg for 5 sessions) without delay if clinical criteria are met 1.

Diagnostic Workup Algorithm

Immediate Clinical Assessment

Examine for the following key diagnostic features that distinguish GBS from other causes:

• Reflexes: Check deep tendon reflexes—areflexia or hyporeflexia is present in most patients at presentation and nearly all at nadir 1
• Pattern of weakness: Rapidly progressive bilateral weakness (though can be asymmetric) that typically starts distally in legs and ascends 1
• Sensory examination: Perform pin-prick testing for distal paresthesias or sensory loss; note that sensory symptoms may present atypically as "sharp zingers" rather than classic numbness 2
• Proximal strength testing: Specifically test hip flexors, as isolated proximal weakness can be an atypical early presentation 2
• Vascular examination: Critical pitfall to avoid—always check distal pulses, limb temperature, and color to exclude arterial occlusion, which can mimic neurological weakness 3
• Timeline: Disease progression to maximum disability typically occurs within 2 weeks; if symptoms peak within 24 hours or after 4 weeks, consider alternative diagnoses 1

Atypical Presentations to Recognize

Be alert for these variant presentations that can delay diagnosis:

• Pain-predominant: Severe diffuse myalgias, back pain, or radicular pain may precede weakness 2, 4
• Autonomic dysfunction: Blood pressure instability, heart rate changes, urinary retention, or bowel dysfunction 1, 4
• Cranial nerve involvement: Bilateral facial palsy, dysphagia, or ophthalmoplegia 1
• Lower extremity edema: Bilateral leg swelling accompanying weakness can be mistaken for other conditions 4
• Pure motor variant: Weakness without sensory signs, potentially with preserved or exaggerated reflexes in AMAN subtype 1

Confirmatory Testing

Lumbar puncture: Obtain CSF analysis showing cytoalbuminologic dissociation (elevated protein >60 mg/dL with normal white blood cell count) 2. This confirms the diagnosis but should not delay treatment initiation if clinical suspicion is high.

Nerve conduction studies and EMG: Perform to confirm diagnosis and classify subtype, but again, do not wait for results before starting treatment 4.

Exclude Alternative Diagnoses

Order the following based on clinical context:

• Spinal imaging (MRI): Only if upper motor neuron signs present or concern for cord compression 2
• CT angiography: If vascular compromise suspected (absent pulses, limb pallor/coldness) 3
• Serum studies: Creatine kinase, thyroid function, acetylcholine receptor antibodies (for myasthenia gravis), serum protein electrophoresis (for POEMS syndrome) 5, 6
• Antiphospholipid antibodies and aPTT: If multiorgan involvement or thrombotic features 7

Treatment Protocol

Immediate Management

Start treatment as soon as GBS is clinically diagnosed—do not wait for confirmatory testing 1, 4. Choose one of the following (both equally effective):

• Intravenous immunoglobulin (IVIG): 0.4 g/kg daily for 5 consecutive days 1
• Plasma exchange: 200-250 ml/kg total volume over 5 sessions 1

Monitoring and Supportive Care

• Respiratory function: Monitor vital capacity and negative inspiratory force frequently, as respiratory failure is the primary cause of mortality
• Autonomic instability: Continuous cardiac monitoring for dysrhythmias and blood pressure fluctuations 1
• Pain management: Address neuropathic, radicular, or muscular pain aggressively 1
• Venous thromboembolism prophylaxis: Immobilized patients require DVT prevention

Prognosis Calculation

Calculate the modified Erasmus GBS Outcome Score (mEGOS) on admission to predict outcome 1. Recovery continues for more than 3 years after onset in many patients, and recurrence is rare (2-5%) 1.

Critical Pitfalls to Avoid

1. Dismissing atypical pain presentations: Myalgias, "sharp zingers," or severe back pain may be the initial presentation before weakness develops 2, 4
2. Missing vascular occlusion: Always examine pulses—arterial occlusion can present identically to neurological weakness 3
3. Delaying treatment for test results: Clinical diagnosis is sufficient to initiate IVIG or plasma exchange 4
4. Overlooking pediatric presentations: Children under 6 years may present with refusal to bear weight, irritability, or unsteady gait rather than classic weakness 1
5. Assuming normal reflexes exclude GBS: Pure motor AMAN variant can have preserved or exaggerated reflexes 1